Clinical Trial Update: Using Less Neurotoxic Drugs in Patients With HAND (MARAND-X) [Phase 4]

View source ↗

Summary

Phase 4 trial update on using less neurotoxic drugs in patients with HIV-associated neurocognitive disorder (HAND), currently terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection
• Hiv-associated Neurocognitive Disorder

Snippet

Sponsor: Giovanni Di Perri | Conditions: Hiv, Neurocognitive Dysfunction | Phase 4 | Status: TERMINATED